4/A: Cue Biopharma Director Receives Stock Grant
Insider Transaction (Form 4/A)
Pamela Garzone, a Director of Cue Biopharma, Inc., received 18,900 shares of common stock on July 9, 2026.
Summary
- Grant/award: acquired 18,900 Common Stock on July 9, 2026; holds 18,900 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Pamela Garzone — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-09 | Grant/award | Common Stock | 18,900 | — | — | 18,900 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-09 | Grant/award (18,900 shares) |
Keywords
insider transaction, Form 4/A, CUE, Cue Biopharma, Inc., neutral, Pamela Garzone
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.